Quest diagnostics inc (DGX)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

906,000

788,000

824,000

696,000

753,000

592,000

883,000

592,000

506,000

757,017

766,222

613,195

366,449

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and Amortization

329,000

309,000

270,000

249,000

304,000

314,000

283,000

287,000

281,000

253,964

256,687

264,593

237,879

Provision for doubtful accounts

11,000

6,000

8,000

7,000

297,000

296,000

270,000

269,000

280,000

291,737

320,974

326,228

300,226

Deferred income tax provision

15,000

73,000

9,000

37,000

112,000

23,000

19,000

7,000

29,000

-18,878

83,120

549

-1,575

Stock-based compensation expense

56,000

61,000

79,000

69,000

52,000

51,000

28,000

50,000

72,000

53,927

75,059

70,581

56,853

(Gains) losses on sale of property, plant and equipment

70,000

-6,000

-2,000

-

-

-

-

-

-

-

-

-

-

Loss (gain) on disposition of business

-

-

-

118,000

334,000

0

0

-

-

-

-

-

-

Payment for debt extinguishment costs

-

-

-

43,000

-

-

-

-

-

-

-

-

-

Excess tax benefits from stock-based compensation arrangements

-

-

-

-

-

-

4,000

4,000

4,000

884

5,540

-2,420

-13,981

Gain on sale of royalty rights

-

-

-

-

-

-

474,000

0

0

-

-

-

-

Asset impairment and loss on sale of business, net

-

-

-

-

-

-

-

86,000

0

0

-

-

-

Provision for special charge

-

-

-

-

-

-

-

-

236,000

0

-

72,650

238,781

Other, net

39,000

-6,000

8,000

2,000

-6,000

12,000

-19,000

8,000

-8,000

-22,967

-29,699

13,772

8,310

Changes in operating assets and liabilities:
Accounts receivable

63,000

65,000

-9,000

42,000

262,000

312,000

247,000

243,000

307,000

309,932

314,102

-282,634

-265,347

Accounts payable and accrued expenses

73,000

-19,000

-8,000

56,000

-24,000

74,000

-21,000

-13,000

-18,000

18,235

56,533

-12,565

-5,431

Settlement of special charge

-

-

-

-

-

-

-

-

241,000

0

314,386

-

-

Settlement and other special charges

-

-

-

-

-

-

-

-

-

-

-

0

-14,013

Income taxes payable

29,000

4,000

16,000

42,000

-41,000

-84,000

-93,000

100,000

39,000

33,732

21,190

24,653

3,213

Termination of interest rate swap agreements

-

-

-

54,000

0

0

-

72,000

0

0

-

-

-

Other assets and liabilities, net

4,000

-31,000

26,000

-25,000

42,000

-2,000

11,000

8,000

-14,000

-16,162

-21,962

-25,553

15,560

Net cash provided by operating activities

1,243,000

1,200,000

1,175,000

1,116,000

821,000

944,000

652,000

1,187,000

895,000

1,118,047

997,418

1,063,049

926,924

Cash flows from investing activities:
Payments to Acquire Businesses, Net of Cash Acquired

58,000

421,000

581,000

139,000

67,000

728,000

213,000

51,000

1,299,000

0

18,295

-8,066

1,535,826

Proceeds from disposition of business

0

2,000

1,000

295,000

0

0

296,000

0

0

-

-

-

-

Proceeds from disposition of property, plant, and equipment

91,000

2,000

1,000

-

-

-

-

-

-

-

-

-

-

Escrow proceeds associated with disposition of business

-

-

-

-

0

-

-

-

-

-

-

-

-

Proceeds from sale of royalty rights

-

-

-

-

-

-

474,000

0

0

-

-

-

-

Sale of securities acquired in business acquisition

-

-

-

-

-

-

-

-

214,000

0

-

-

-

Capital expenditures

400,000

383,000

252,000

293,000

263,000

308,000

231,000

182,000

161,000

205,400

166,928

212,681

219,101

Investment in equity method investee

-

-

-

-

33,000

0

0

-

-

-

-

-

-

Increase in investments and other assets

44,000

1,000

-1,000

-10,000

-1,000

-11,000

-2,000

-16,000

-3,000

11,110

10,681

-5,732

4,266

Net cash used in investing activities

-411,000

-801,000

-830,000

-127,000

-362,000

-1,025,000

328,000

-217,000

-1,243,000

-216,510

-195,904

-198,883

-1,759,193

Cash flows from financing activities:
Proceeds from borrowings

2,281,000

2,090,000

205,000

1,869,000

2,453,000

2,018,000

896,000

715,000

2,689,000

0

1,245,525

22,929

3,754,490

Repayments of debt

1,449,000

1,966,000

182,000

1,728,000

2,537,000

1,647,000

900,000

1,369,000

1,710,000

169,491

-1,218,538

-481,870

-2,705,369

(Decrease) increase in book overdrafts

-

-

-

-

-

-

-

-

-

-

-

-

-24,950

Purchases of treasury stock

353,000

322,000

465,000

590,000

224,000

132,000

1,037,000

200,000

935,000

750,000

499,991

253,997

145,660

Exercise of stock options

119,000

99,000

130,000

73,000

60,000

78,000

138,000

162,000

137,000

48,535

87,120

30,511

80,928

Employee payroll tax withholdings on stock issued under stock-based compensation plans

16,000

21,000

23,000

10,000

7,000

6,000

4,000

4,000

4,000

884

5,540

2,420

13,981

Dividends paid

286,000

266,000

247,000

223,000

212,000

187,000

185,000

108,000

65,000

71,321

74,748

77,964

77,327

Distributions to noncontrolling interest partners

54,000

54,000

51,000

41,000

42,000

31,000

32,000

38,000

36,000

36,739

35,524

32,931

24,678

Payment of debt extinguishment costs

-

-

-

43,000

-

-

-

-

-

-

-

-

-

Contributions from noncontrolling interest partners

0

16,000

4,000

0

63,000

0

0

-

-

-

-

-

-

Payment of deferred business acquisition consideration

-

-

-

-

51,000

0

0

-

-

-

-

-

-

Other financing activities, net

-17,000

23,000

37,000

-45,000

-21,000

-7,000

10,000

12,000

-20,000

-8,360

-30,588

13,088

-21,192

Net cash (used in) provided by financing activities

225,000

-401,000

-592,000

-738,000

-518,000

86,000

-1,106,000

-822,000

64,000

-986,492

-521,204

-777,814

850,223

Net change in cash and cash equivalents and restricted cash

1,057,000

-2,000

-247,000

251,000

-59,000

5,000

-126,000

148,000

-284,000

-84,955

280,310

86,352

17,954

Change in cash and cash equivalents included in assets held for sale

-

-

-

-

-

-

17,000

-17,000

0

0

-

-

-